Profit

'DLF may earn Rs 1500 crore via asset monetisation'

PUBLISHED ON: September 14, 2011 | Duration: 8 min, 57 sec

facebooktwitteremailkoo
loading..
Prakash Agarwal, Equity analyst (India Pharma and Property) at RBS says that Ranbaxy is all set to launch Lipitor in US at time. He expects asset monetisation from DLF to the tune of Rs 1500 crore in the next three months.
ALSO WATCH
Exclusive: The Cash-For-'Bail' Tapes

................................ Advertisement ................................

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com